XRAYDENTSPLY SIRONA Inc.
Price
-31%1YEnd-of-day closes, not the intraday tick.
Survival is the story here: start there
Quality mixed, hard red flags, undemanding price, growth steady, the market against it.
DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) is the world’s largest diversified manufacturer of professional dental products and technologies, with a 139-year history of innovation and service to the dental industry and a vision of improving oral health and continence care globally. Dentsply Sirona develops, manufactures, and markets comprehensive solutions, including technologically advanced dental equipment supported by cloud-enabled software solutions as well as dental products and healthcare consumable products in urology and enterology under a strong portfolio of world-class brands.
In the company’s own words · 10-K filed Feb 26, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
DENTSPLY SIRONA Inc. (XRAY) reported revenue of $898M in Q2 2026 (quarter ended Jun 30, 2026), down 4.1% from the same quarter a year earlier. That came with a gross margin of 55% and net income of $37M (4.1% of revenue). For the full year FY2025, revenue was $3.68B (−3.0% year on year) and net income −$598M. Its largest product in Q2 2026 was Implants And Prosthetics at $157M, 36% of the disclosed total, just ahead of Equipment And Instruments at 31%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 7, 2026Dentsply Sirona Reports Second Quarter 2026 Results.Earnings release · press release
- Aug 6, 2026Dentsply Sirona Reports Second Quarter 2026 Results.Material event (exhibits only) · press release
- Jun 11, 2026On June 1, 2026, the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”) appointed John C. Fortson as the Company’s Executive Vice President & Chief Financial Officer, effective as of July 20, 2026 (the “Effective Date”)Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $436.0MThe company’s own SEC segment disclosure.
- Implants And Prosthetics$157.0M36%
- Equipment And Instruments$137.0M31%
- CADCAM$102.0M23%
- Orthodontics$40.0M9%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Instruments & Supplies
Ranks #16 of 21 by RyuScore